Objective-To compare the effects of dual chamber pacing (DDD) and ventricular rate adaptive pacing (activity sensing) (VVIR) However, it is not clear whether either of these rate responsive modes is better than the other. Because the Synergyst I (Medtronic) pacemaker can operate in the DDD and activity sensing VVIR pacing modes we were able to compare the effects of these two modes in the same patient.
plete heart block.
Design-Double blind crossover comparison with one month in each pacing mode. Patients-10 consecutive patients aged presenting with complete anterograde atrioventricular block at rest and on exercise and with an intact atrial rate response received Synergyst I (Medtronic) pacemakers. Main outcome measures-Symptom scores, maximal exercise performance on a treadmill, and the plasma concentrations of atrial natriuretic peptide, adrenaline, and noradrenaline. Results-No significant differences were identified between pacing modes in symptom scores for dyspnoea, fatigue, and mood disturbance; exercise time; and maximal oxygen consumption. One patient with intact ventriculoatrial conduction developed pacemaker syndrome during VVIR pacing. Resting plasma concentrations of atrial natriuretic peptide were raised in complete heart block and were restored to normal by DDD pacing but not by VVIR pacing. Resting plasma catecholamine concentrations were normal in complete heart block and in both pacing modes. During exercise the increase in the concentrations of all three hormones was similar in both pacing modes. Conclusions-In patients with complete anterograde and retrograde atrioventricular block, symptoms and maximal exercise performance were no better during DDD than during VVIR pacing.
In most patients who need permanent pacemakers, symptoms and exercise performance are better with rate responsive pacing than with fixed rate ventricular pacing. This has been shown in comparisons with dual chamber (DDD) pacing1-3 and also with various sensor-driven single chamber ventricular rate responsive (VVIR) systems." However, it is not clear whether either of these rate responsive modes is better than the other. Because the Synergyst I (Medtronic) pacemaker can operate in the DDD and activity sensing VVIR pacing modes we were able to compare the effects of these two modes in the same patient.
Patients and methods
The study was designed as a double blind prospective crossover comparison of the effects of DDD and VVIR pacing on symptoms, maximal exercise capacity, and plasma concentrations of adrenaline, noradrenaline, and atrial natriuretic peptide in complete heart block. It was approved by the ethics committee of Glasgow Royal Infirmary and all patients gave written informed consent before entry. There were seven men and three women (mean age 56 years (range 23-74)). The underlying cardiac diagnoses were ischaemic heart disease (two), hypertension (two), congenital heart block (two), and idiopathic fibrosis of the conducting tissue (four). Only two patients were receiving cardiovascular drugs and treatment was not changed during the course of the study. at the end of which they crossed over to the opposite mode for a further month. Peripheral venous blood samples were taken from indwelling cannulas at rest before implantation of the pacemaker, and at rest and after exercise after each one month period. Symptom questionnaires were also completed at each visit. All pacemaker programming and electrocardiographic monitoring during exercise testing was performed by one operator (CW). All of the exercise tests were supervised by a different observer (RC) who was not aware of the pacing mode and was screened from the electrocardiographic monitor during testing.
SYMPTOM SCORES
Symptoms were assessed at the end of each one month period by a self administered questionnaire. This questionnaire was developed at McMaster University and has been used in a previous study to compare different pacing modes.4 Three sets of eight questions related to dyspnoea, fatigue, and mood disturbance were answered by marking an ungraduated 100 mm linear visual analogue scale cued with "very much" and "not at all". The distances of all the marks for each category of questions were summed: a maximum score of 800 was possible.
EXERCISE PROTOCOL
Maximal symptom limited treadmill exercise tests with concurrent measurement of respiratory gas exchange were used. In our laboratory the limb of the breathing circuit for inspiration is fitted with a turbine ventilometer and the limb for expiration includes a mixing chamber from which mixed expiratory gases are measured by polarographic oxygen and infrared carbon analysers. The output of the ventilometer and gas analysers are processed by an on line microcomputer (PK Morgan Exercise Test System) to allow continuous measurement of gas exchange and inspired minute ventilation. For the exercise protocol patients were monitored at rest for two minutes to establish a steady state, then they performed incremental treadmill exercise at a fixed gradient of 10 degrees starting at one mile per hour and increasing by 0 5 miles per hour every minute. Maximal oxygen consumption7 and the respiratory anaerobic threshold8 were determined by standard criteria. We used a fixed gradient because activity sensing pacemakers respond to increases in treadmill speed rather than incline.59 EJECTION FRACTION This was calculated from cross sectional echocardiographic images obtained in DDD mode. We used an area x length formula.
ASSAYS
Atrial natriuretic peptide was measured by radioimmunoassay'0 (normal range 5-50 pg/ml). Catecholamines were measured by radioenzymatic assay" (normal values adrenaline <1 -0 nmol/l and noradrenaline < 5 0 nmol/1).
STATISTICAL ANALYSIS
To assess the distribution of the data derived from this study we calculated the standardised skewness and kurtosis of each of the variables.
Normally distributed values were expressed as mean (SEM) Though the program settings were aimed at allowing a similar maximum heart rate in both pacing modes, the maximum heart rate achieved was significantly higher in the DDD mode than in the VVIR mode: 136 (4) Although the median concentration on exercise was higher in VVIR than DDD with 7/10 v 4/10 subjects reaching concentrations above the normal range, the difference between the modes just failed to reach statistical significance (exact p value = 0-05). There was no difference between pacing modes in either the absolute or percentage increase in atrial natriuretic peptide on exercise. The patient with pacemaker syndrome during VVIR pacing had raised plasma atrial natriuretic peptide at rest with a substantial rise to 196 pg/ml on exercise. In DDD mode his atrial natriuretic peptide concentration was normal at rest and remained within the normal range on exercise.
CATECHOLAMINES (TABLE 2) Before pacemaker implantation one patient had a slightly raised plasma concentration of noradrenaline at rest (5 3 nmol/l), but otherwise both adrenaline and noradrenaline concentrations were normal. Resting concentrations were all within normal limits in both pacing modes and there was no difference between modes in either the resting or exercise concentrations of adrenaline or noradrenaline. Though there was an overall increase in the concentration of both catecholamines on exercise in both modes, there was no difference between modes in either the absolute or percentage increases. restore normal concentrations. It has previously been shown that atrial natriuretic peptide concentrations rise on exercise23 24 and during ventriculoatrial pacing.25 By providing higher ventricular rates on exercise, VVIR pacing increases the frequency of asynchronous atrial contraction, which may result in an augmented rise in atrial natriuretic peptide on exercise even in the absence ofintact ventriculoatrial conduction. We did find a trend towards higher concentrations on exercise in the VVIR mode than in the DDD mode (exact p value = 005), but there was no difference between modes in either the absolute or percentage change on exercise. As in published reports, our only patient with pacemaker syndrome during VVIR pacing had very high plasma concentrations of atrial natriuretic peptide.26 However, the relevance of this finding to the vasomotor changes and symptoms of pacemaker syndrome remains unclear.24
In patients with impaired ventricular function cardiac release of noradrenaline on exercise is higher during VVI pacing than during atrial synchronous pacing.27 This accounts for the much greater increases in stroke volume on exercise seen in VVI mode and partly offsets the lack of a rate response.28
Though we only measured peripheral venous catecholamine concentrations, our results suggest that VVIR pacing is not associated with undue activation of the sympathetic nervous system either at rest or on exercise.
Single chamber ventricular pacemakers are easier and cheaper to implant than DDD systems and they avoid the problems of atrial lead displacement, atrial malsensing, and cross-talk. They can continue to provide rate response if atrial fibrillation or chronotropic incompetence develop. A potential disadvantage of VVIR pacing is the possible increased incidence of the development of atrial fibrillation with its attendant risk of thromboembolism. However, though this has been shown to be relevant in patients with sinus node dis- 
Aspirin
The success of quinine from 1630 onwards in treating malaria led to its use in other febrile conditions. So when the Reverend Edward Stone in 1763 noticed that powdered bark of the willow tree, Salix species (Salicaceae), had a bitter taste like quinine he used it as a substitute for the expensive imported cinchona bark. Its active principle-salicin, which is converted into salicylic acid in the body-was isolated in 1830 and introduced for the treatment of acute rheumatic fever by Dr Thomas Maclagan of Dundee in 1876. He used it in the erroneous belief, based on the Doctrine of Signatures, that because the disease was prevalent in cold damp localities Salix, a typical marsh plant, would be nature's remedy. None the less, he got the right answer.
Salicylic acid was originally produced in 1835 from salicylaldehyde found in Spiraea ulmaria, now Filipendula ulmaria (Rosaceae), the meadowsweet. It became freely available only with the development of a synthetic process in 1874. Its use as an "internal antiseptic" in typhoid fever revealed its antipyretic property. This, together with Maclagan's work, led to its use in rheumatic fever and other rheumatic diseases.
After gastric irritation prevented his father from taking sodium salicylate to treat his chronic arthritis Felix Hoffman, a chemist with the Bayer Company, produced acetylsalicylic acid in 1899 (it had been synthesised elsewhere in 1853). He gave it the trade name Aspirin (a for acetyl; spir for spiraea; and in, a common ending for drugs). This is now the generic name.
The family Salicaceae consists mainly of trees and shrubs from the northern temperate region and has only three genera. The Rosaceae are more numerous (over 100 genera and 3000 species) and more widely distributed. They vary from trees to herbs and include apples, plums, and strawberries. Some of the Rosaceae species yield vitamin C but otherwise neither the Rosaceae nor the Salicaceae contain other important medicines. 
